[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

van Eckert et al. - Google Patents

Working Group on Prolamin Analysis and Toxicity (PWG)

van Eckert et al.

View HTML
Document ID
5455767310881875754
Author
van Eckert R
Bond J
Ciclitira P
Ellis H
Rawson P
Klein C
Stern M
Jordan T

External Links

Snippet

The 25th meeting of the Working Group on Prolamin Analysis and Toxicity (PWG) was held at Classic Congress Hotel, Fellbach, Germany, from September 29 to October 2, 2011. This time the PWG was hosted by the German Coeliac Society, namely Sofia Beisel, Judith Suck …
Continue reading at www.wgpat.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Lindfors et al. Coeliac disease
Brouns et al. Adverse reactions to wheat or wheat components
Fric et al. Celiac disease, gluten-free diet, and oats
Pulido et al. Introduction of oats in the diet of individuals with celiac disease: a systematic review
Sapone et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Arendt et al. Gluten-free cereal products and beverages
Koehler et al. Celiac disease and gluten: multidisciplinary challenges and opportunities
Ciclitira et al. Gluten-free diet—what is toxic?
Zevallos et al. Gastrointestinal effects of eating quinoa (Chenopodium quinoaWilld.) in celiac patients
Arentz-Hansen et al. The molecular basis for oat intolerance in patients with celiac disease
Wieser et al. The biochemical basis of celiac disease
Colgrave et al. Proteomic profiling of 16 cereal grains and the application of targeted proteomics to detect wheat contamination
Ballabio et al. Molecular characterisation of 36 oat varieties and in vitro assessment of their suitability for coeliacs’ diet
Spaenij-Dekking et al. A novel and sensitive method for the detection of T cell stimulatory epitopes of α/β-and γ-gliadin
AU2005218391B2 (en) Method of detecting allergen
Slot et al. Immunochemical detection methods for gluten in food products: where do we go from here?
Elli et al. Immunological effects of transglutaminase-treated gluten in coeliac disease
Mazzarella et al. Reintroduction of gluten following flour transamidation in adult celiac patients: a randomized, controlled clinical study
Koning Adverse effects of wheat gluten
Segura et al. New insights into non-dietary treatment in celiac disease: Emerging therapeutic options
Allred et al. The celiac patient antibody response to conventional and gluten-removed beer
Colombo et al. Ancient and modern cereals as ingredients of the gluten-free diet: are they safe enough for celiac consumers?
Ribeiro et al. Advances in quantification and analysis of the celiac‐related immunogenic potential of gluten
Zhu et al. How does a celiac iceberg really float? The relationship between celiac disease and gluten
Mennini et al. Anaphylaxis after wheat ingestion in a patient with coeliac disease: two kinds of reactions and the same culprit food